Literature DB >> 16353937

Mu opioid receptor regulation and opiate responsiveness.

Kirsten M Raehal1, Laura M Bohn.   

Abstract

Opiate drugs such as morphine are well known for their ability to produce potent analgesia as well as such unwanted side effects as tolerance, physical dependence, respiratory suppression and constipation. Opiates act at opioid receptors, which belong to the family of G protein-coupled receptors. The mechanisms governing mu opioid receptor (muOR) regulation are of particular interest since morphine and other clinically important analgesics produce their pharmacological effects through this receptor. Here we review recent advances in understanding how opioid receptor regulation can impart differential agonist efficacy produced in vivo.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16353937      PMCID: PMC2751262          DOI: 10.1208/aapsj070360

Source DB:  PubMed          Journal:  AAPS J        ISSN: 1550-7416            Impact factor:   4.009


  63 in total

1.  Differential regulation of beta-arrestin 1 and beta-arrestin 2 gene expression in rat brain by morphine.

Authors:  X L Fan; J S Zhang; X Q Zhang; W Yue; L Ma
Journal:  Neuroscience       Date:  2003       Impact factor: 3.590

2.  A role for heterodimerization of mu and delta opiate receptors in enhancing morphine analgesia.

Authors:  Ivone Gomes; Achla Gupta; Julija Filipovska; Hazel H Szeto; John E Pintar; Lakshmi A Devi
Journal:  Proc Natl Acad Sci U S A       Date:  2004-03-24       Impact factor: 11.205

Review 3.  G protein-coupled receptor kinase/beta-arrestin systems and drugs of abuse: psychostimulant and opiate studies in knockout mice.

Authors:  Laura M Bohn; Raul R Gainetdinov; Marc G Caron
Journal:  Neuromolecular Med       Date:  2004       Impact factor: 3.843

4.  Differential mechanisms of morphine antinociceptive tolerance revealed in (beta)arrestin-2 knock-out mice.

Authors:  Laura M Bohn; Robert J Lefkowitz; Marc G Caron
Journal:  J Neurosci       Date:  2002-12-01       Impact factor: 6.167

5.  Morphine side effects in beta-arrestin 2 knockout mice.

Authors:  Kirsten M Raehal; Julia K L Walker; Laura M Bohn
Journal:  J Pharmacol Exp Ther       Date:  2005-05-25       Impact factor: 4.030

6.  Trafficking patterns of beta-arrestin and G protein-coupled receptors determined by the kinetics of beta-arrestin deubiquitination.

Authors:  Sudha K Shenoy; Robert J Lefkowitz
Journal:  J Biol Chem       Date:  2003-02-06       Impact factor: 5.157

7.  Morphine acutely regulates opioid receptor trafficking selectively in dendrites of nucleus accumbens neurons.

Authors:  Helena Haberstock-Debic; Marc Wein; Michel Barrot; Eric E O Colago; Zia Rahman; Rachael L Neve; Virginia M Pickel; Eric J Nestler; Mark von Zastrow; Adena L Svingos
Journal:  J Neurosci       Date:  2003-05-15       Impact factor: 6.167

8.  Decreased immunodensities of micro-opioid receptors, receptor kinases GRK 2/6 and beta-arrestin-2 in postmortem brains of opiate addicts.

Authors:  Marcel Ferrer-Alcón; Romano La Harpe; Jesús A García-Sevilla
Journal:  Brain Res Mol Brain Res       Date:  2004-02-05

9.  Heterodimerization of substance P and mu-opioid receptors regulates receptor trafficking and resensitization.

Authors:  Manuela Pfeiffer; Susanne Kirscht; Ralf Stumm; Thomas Koch; Daifei Wu; Magdalena Laugsch; Helmut Schröder; Volker Höllt; Stefan Schulz
Journal:  J Biol Chem       Date:  2003-10-07       Impact factor: 5.157

10.  Enhanced rewarding properties of morphine, but not cocaine, in beta(arrestin)-2 knock-out mice.

Authors:  Laura M Bohn; Raul R Gainetdinov; Tatyana D Sotnikova; Ivan O Medvedev; Robert J Lefkowitz; Linda A Dykstra; Marc G Caron
Journal:  J Neurosci       Date:  2003-11-12       Impact factor: 6.167

View more
  33 in total

1.  Chronic methadone treatment shows a better cost/benefit ratio than chronic morphine in mice.

Authors:  Johan Enquist; Madeline Ferwerda; Laura Milan-Lobo; Jennifer L Whistler
Journal:  J Pharmacol Exp Ther       Date:  2011-11-07       Impact factor: 4.030

Review 2.  Effects of opiates and HIV proteins on neurons: the role of ferritin heavy chain and a potential for synergism.

Authors:  Lindsay Festa; Olimpia Meucci
Journal:  Curr HIV Res       Date:  2012-07       Impact factor: 1.581

Review 3.  Functional selectivity at the μ-opioid receptor: implications for understanding opioid analgesia and tolerance.

Authors:  Kirsten M Raehal; Cullen L Schmid; Chad E Groer; Laura M Bohn
Journal:  Pharmacol Rev       Date:  2011-08-26       Impact factor: 25.468

4.  RGS9-2 modulates nociceptive behaviour and opioid-mediated synaptic transmission in the spinal dorsal horn.

Authors:  Maria Martha Papachatzaki; Zsófia Antal; Dimitra Terzi; Péter Szücs; Venetia Zachariou; Miklós Antal
Journal:  Neurosci Lett       Date:  2011-06-29       Impact factor: 3.046

5.  Absence of μ opioid receptor mRNA expression in astrocytes and microglia of rat spinal cord.

Authors:  Sheng-Chin Kao; Xiuli Zhao; Chun-Yi Lee; Fidelis E Atianjoh; Estelle B Gauda; Myron Yaster; Yuan-Xiang Tao
Journal:  Neuroreport       Date:  2012-04-18       Impact factor: 1.837

Review 6.  Targeting TRPV1 as an alternative approach to narcotic analgesics to treat chronic pain conditions.

Authors:  Louis S Premkumar
Journal:  AAPS J       Date:  2010-05-04       Impact factor: 4.009

Review 7.  Changing mechanisms of opiate tolerance and withdrawal during early development: animal models of the human experience.

Authors:  Gordon A Barr; Anika McPhie-Lalmansingh; Jessica Perez; Michelle Riley
Journal:  ILAR J       Date:  2011

8.  Interaction of the mu-opioid receptor with GPR177 (Wntless) inhibits Wnt secretion: potential implications for opioid dependence.

Authors:  Jay Jin; Saranya Kittanakom; Victoria Wong; Beverly A S Reyes; Elisabeth J Van Bockstaele; Igor Stagljar; Wade Berrettini; Robert Levenson
Journal:  BMC Neurosci       Date:  2010-03-09       Impact factor: 3.288

9.  Synthesis, modeling, and pharmacological evaluation of UMB 425, a mixed μ agonist/δ antagonist opioid analgesic with reduced tolerance liabilities.

Authors:  Jason R Healy; Padmavani Bezawada; Jihyun Shim; Jace W Jones; Maureen A Kane; Alexander D MacKerell; Andrew Coop; Rae R Matsumoto
Journal:  ACS Chem Neurosci       Date:  2013-06-11       Impact factor: 4.418

10.  A novel type of glial cell in the retina is stimulated by insulin-like growth factor 1 and may exacerbate damage to neurons and Müller glia.

Authors:  Andy J Fischer; Melissa A Scott; Christopher Zelinka; Patrick Sherwood
Journal:  Glia       Date:  2010-04-15       Impact factor: 7.452

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.